ASAIO JOURNAL

简称 ASAIO J ·UNITED STATES ·出版周期 Bimonthly ·年均收录 135 篇

2.3

最新影响因子

12.50%

自引率

容易

投稿难度

偏慢,4-8周

审稿周期

期刊简介

ASAIO JOURNAL是一本国际知名的生物医学工程期刊，ISSN号为1058-2916，由美国人工内脏器官学会（American Society for Artificial Internal Organs）出版，出版地为美国，出版周期为双月刊。该期刊由Lippincott Williams & Wilkins出版社发行，目前被SCI收录，2022年影响因子为4.2，属于中科院医学大类3区。该期刊为非开放获取（非OA）期刊。ASAIO JOURNAL主要聚焦于人工器官、生物材料、体外循环、机械辅助装置、组织工程和再生医学等领域的研究，发文特点是涵盖基础研究、临床转化和技术创新，尤其重视跨学科合作与临床应用。杂志质量较高，审稿严格，但投稿周期相对较长，且对研究创新性和技术实用性要求较高，可能存在拒稿率较高的风险。总体而言，该期刊在生物医学工程领域具有较高的学术影响力，适合从事人工器官和相关技术研究的学者投稿。

影响因子趋势

近期发表

Chorda Tendinea Obstruction of Impella Causing Massive Hemolysis Detected by Methemoglobinemia: A Case Report 2026-09-14

Extracorporeal Membrane Oxygenation Combined With Embolectomy May Yield Better Outcomes Than Extracorporeal Membrane Oxygenation Alone or With Thrombolysis for Acute High-Risk Pulmonary Embolism 2026-09-11

Does Earlier Right Ventricular Assist Device Implant Confer a Survival Advantage? 2026-09-11

Hybrid Respiratory Dialysis for Ultra-Low Blood-Flow Extracorporeal CO2 Removal 2026-09-10

Letter to the Editor: Side Port Resistance Limits Distal Perfusion Flow (Matsumoto et al.) 2026-09-10

Device Failure on Extracorporeal Life Support: Insights From the Manufacturer and User Facility Device Experience Database 2026-09-10

Response to the Letter to the Editor Regarding “Side Port Resistance Limits Distal Perfusion Flow” 2026-09-10

Superior Vena Cava Syndrome During Femoro-Femoral Veno-Venous Extracorporeal Membrane Oxygenation: A Case Report 2026-09-10

C-Reactive Protein Predicts Outcomes in HeartMate 3 Left Ventricular Assist Device Recipients 2026-09-10

Driveline Relocation With Omentoplasty for Severe Ventricular Assist Device-Specific Infection 2026-09-09